NCT06825442

Brief Summary

Several classifications exist to describe peri-operative complications including the Clavien-Dindo classification which is easily applicable to laparoscopic removal of endometriosis in all stages and is widely recommended for the evaluation of outcomes of endometriosis surgery. The most widely used staging system is the one reviewed by the American Society of Reproductive Medicine (rASRM) which, however, does not study DIE. In contrast, the ENZIAN score studies the anterior, posterior and lateral compartment of the pelvis and provides more reliable information on the extent of lesions. On the other hand, the rASRM and ENZIAN classification systems expressing the disease burden only indirectly correlate with the risk of postoperative complications and are not good predictors of post-surgical complications \[19\]. There are no studies in the literature evaluating the association of these complications with aspects such as the technical difficulty of surgical removal of endometriosis in relation to the extent of the disease. The study of perioperative complications is essential in endometriosis surgery, so having a classification system capable of predicting complications on the basis of surgical complexity could guide clinical practice and post-operative management of patients with DIE. This study could provide useful elements not only to improve the post-operative outcome of the operated patients, but also to identify preoperatively those pictures of DIE for which the surgeon will have to pay more attention because they have a higher risk of perioperative adverse events.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
198

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 10, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

February 1, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 13, 2025

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 2, 2025

Completed
Last Updated

February 13, 2025

Status Verified

November 1, 2024

Enrollment Period

29 days

First QC Date

January 10, 2025

Last Update Submit

February 11, 2025

Conditions

Keywords

endometriosissurgerysurgical complicationsAAGL Classification 2021

Outcome Measures

Primary Outcomes (1)

  • Association between AAGL staging and the occurrence of peri-operative complications

    Occurrence of (one or more) peri-operative complications

    within 90 days from surgery

Secondary Outcomes (6)

  • Association between the AAGL score, ENZIAN classification, r-ASRM stage and the occurrence of peri-operative complications

    within 90 days from surgery

  • Occurrence of peri-operative complications in patients undergoing surgery for DIE compared to patients undergoing surgery for DIE with hysterectomy

    within 90 days from surgery

  • Occurrence of peri-operative complications in patients who underwent preoperative medical therapy compared to patients who did not

    within 90 days from surgery

  • Occurrence of peri-operative complications in patients who underwent peri-operative medical therapy compared to patients who discontinued medical therapy close to surgery

    within 90 days from surgery

  • Occurrence of clinical/radiological recurrence of disease at 24 months in patients who underwent peri-operative medical therapy compared to patients who discontinued medical therapy close to surgery

    24 months after surgery

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Women of childbearing age with endometriosis undergoing complete laparoscopic removal of endometriotic lesions between January 2018 and December 2023 consecutively

You may qualify if:

  • years to 55 years;
  • Pelvic ultrasound and/or radiological (MRI/ CT scan with rectal insufflation) diagnosis of endometriosis and surgery;
  • At least 90 days of follow-up after surgery;
  • Acquisition of informed consent for participation in the study and processing of data

You may not qualify if:

  • Gynaecological oncology;
  • Incomplete resection of macroscopic endometriotic lesions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, 40138, Italy

Location

MeSH Terms

Conditions

Endometriosis

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Diego Raimondo, MD

    IRCCS Azienda Ospedaliero-Universitaria di Bologna

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Diego Raimondo, MD

CONTACT

Pierluigi Celerino, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2025

First Posted

February 13, 2025

Study Start

February 1, 2025

Primary Completion

March 2, 2025

Study Completion

May 2, 2025

Last Updated

February 13, 2025

Record last verified: 2024-11

Locations